Perioperative management of hypertrophic cardiomyopathy for patients undergoing noncardiac surgery

  • Omae Takeshi
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Candiotti A Keith
    Department of Anesthesiology, Jackson Memorial Hospital
  • Koh Keito
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Kumemura Masateru
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Sakuraba Sonoko
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Iwatsubo Chie
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Yasui Mariko
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital
  • Katsuda Yosuke
    Department of Anesthesiology and Pain Clinic, Juntendo University Shizuoka Hospital

書誌事項

タイトル別名
  • ― Perioperative management of HCM ―

この論文をさがす

説明

This report reviews current knowledge concerning the pathophysiology, hemodynamics, and perioperative management of hypertrophic cardiomyopathy (HCM). HCM is a primary myocardial disease that causes ventricular hypertrophy. This condition occurs in at least 1 per 200 individuals in the general population, and many patients with HCM have a family history of HCM inherited in an autosomal dominant pattern. HCM can cause atrial fibrillation, heart failure, and sudden death with ventricular fibrillation. The incidence of perioperative complications increases in correlation with moderate or severe mitral regurgitation, significant left ventricular outflow tract (LVOT) pressure gradient, heart failure with reduced ejection fraction (EF), and heart failure with preserved EF. Patients with HCM should be handled in a manner similar to that used in case of patients with aortic stenosis. The management of hemodynamic status ranges from minimally invasive monitoring for mild cases to monitoring using transesophageal echocardiography (TEE) for severe cases. TEE is useful for patients with HCM as it can evaluate morphometric images and systolic and diastolic function. The severity of HCM and LVOT obstruction is correlated with the incidence of cardiovascular complications. Perioperative management should also be based on the pathophysiological knowledge of HCM.

収録刊行物

  • 循環制御

    循環制御 42 (1), 17-29, 2021

    日本循環制御医学会

詳細情報 詳細情報について

  • CRID
    1390289687381992320
  • NII論文ID
    130008102491
  • DOI
    10.11312/ccm.42.17
  • ISSN
    03891844
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ